Companies / Cytokinetics Inc / Activity
Activity — Cytokinetics Inc
157 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| May 27, 2026 | Bhanji Muna Director | Grant | Common Stock | $0 | +3K +12.13% | 26,361 0.02% of shares | low |
| May 27, 2026 | Daly James M Director | Grant | Common Stock | $0 | +3K +734.79% | 3,239 <0.01% of shares | low |
| May 27, 2026 | Harrington Robert Arthur Director | Grant | Common Stock | $0 | +3K +15.06% | 21,781 0.02% of shares | low |
| May 27, 2026 | Henderson John T Director | Grant | Common Stock | $0 | +3K +3.79% | 78,088 0.06% of shares | low |
| May 27, 2026 | Kaye Edward M. MD Director | Grant | Common Stock | $0 | +3K +27.51% | 13,216 <0.01% of shares | low |
| May 27, 2026 | Parshall B Lynne Director | Grant | Common Stock | $0 | +3K +15.90% | 20,784 0.01% of shares | low |
| May 27, 2026 | Landry Robert E Director | Grant | Common Stock | $0 | +3K +38.88% | 10,184 <0.01% of shares | low |
| May 27, 2026 | Wierenga Wendell Director | Grant | Common Stock | $0 | +3K +8.74% | 35,488 0.03% of shares | low |
| May 27, 2026 | Wysenski Nancy Director | Grant | Common Stock | $0 | +3K +9.18% | 33,917 0.02% of shares | low |
| Mar 15, 2026 | Lee Sung Executive | Grant | Common Stock | $0 | +21K +28.91% | 92,062 0.07% of shares | low |
| Mar 15, 2026 | Hessekiel Jeffrey Executive | Grant | Common Stock | $0 | +21K +23.65% | 107,943 0.08% of shares | low |
| Mar 15, 2026 | Malik Fady Ibraham Executive | Grant | Common Stock | $0 | +27K +19.70% | 165,935 0.12% of shares | low |
| Mar 15, 2026 | Blum Robert I CEO | Grant | Common Stock | $0 | +75K +19.21% | 466,931 0.34% of shares | low |
| Mar 15, 2026 | Callos Andrew Executive | Grant | Common Stock | $0 | +13K +19.44% | 81,824 0.06% of shares | low |
| Mar 15, 2026 | Callos Andrew Executive | Grant | Common Stock | $0 | +21K +43.14% | 68,504 0.05% of shares | low |
| Apr 15, 2026 | Wysenski Nancy Director | Grant | Common Stock | $6.2K | +95 +0.31% | 31,066 0.02% of shares | low |
| Apr 15, 2026 | Wierenga Wendell Director | Grant | Common Stock | $6.2K | +95 +0.29% | 32,637 0.02% of shares | low |
| Jan 15, 2026 | Wysenski Nancy Director | Grant | Common Stock | $6.2K | +98 +0.32% | 30,971 0.02% of shares | low |
| Jan 15, 2026 | Wierenga Wendell Director | Grant | Common Stock | $6.2K | +98 +0.30% | 32,542 0.02% of shares | low |
| Jun 24, 2026 | Lee Sung Executive | Exercise | Common Stock | $8.3K | +188 +0.19% | 100,016 0.07% of shares | low |
| Jun 29, 2026 | Lee Sung Executive | Exercise | Common Stock | $8.3K | +188 +0.29% | 65,532 0.05% of shares | low |
| Jun 29, 2026 | Lee Sung Executive | Exercise | Common Stock | $8.3K | +188 +0.30% | 63,409 0.05% of shares | low |
| Apr 7, 2026 | Malik Fady Ibraham Executive | Exercise | Common Stock | $10.6K | +1K +0.65% | 154,902 0.11% of shares | low |
| Apr 15, 2026 | Kaye Edward M. MD Director | Grant | Common Stock | $12.5K | +191 +1.88% | 10,365 <0.01% of shares | low |
| Apr 15, 2026 | Harrington Robert Arthur Director | Grant | Common Stock | $12.5K | +191 +1.02% | 18,930 0.01% of shares | low |
| Apr 15, 2026 | Daly James M Director | Grant | Common Stock | $12.5K | +191 +96.95% | 388 <0.01% of shares | low |
| Jan 15, 2026 | Daly James M Director | Grant | Common Stock | $12.5K | +197 | 197 <0.01% of shares | low |
| Jan 15, 2026 | Kaye Edward M. MD Director | Grant | Common Stock | $12.5K | +197 +1.97% | 10,174 <0.01% of shares | low |
| Jan 15, 2026 | Harrington Robert Arthur Director | Grant | Common Stock | $12.5K | +197 +1.06% | 18,739 0.01% of shares | low |
| Jan 15, 2026 | Henderson John T Director | Grant | Common Stock | $21.2K | +334 +0.45% | 74,912 0.05% of shares | low |
| Apr 15, 2026 | Henderson John T Director | Grant | Common Stock | $21.2K | +325 +0.43% | 75,237 0.05% of shares | low |
| Jun 23, 2026 | Malik Fady Ibraham Executive | Exercise | Common Stock | $27.3K | +4K +2.27% | 157,402 0.11% of shares | low |
| Jun 9, 2026 | Malik Fady Ibraham Executive | Exercise | Common Stock | $27.3K | +4K +2.27% | 157,402 0.11% of shares | low |
| May 19, 2026 | Malik Fady Ibraham Executive | Exercise | Common Stock | $27.3K | +4K +2.27% | 157,402 0.11% of shares | low |
| May 5, 2026 | Malik Fady Ibraham Executive | Exercise | Common Stock | $27.3K | +4K +2.27% | 157,402 0.11% of shares | low |
| Apr 21, 2026 | Malik Fady Ibraham Executive | Exercise | Common Stock | $27.3K | +4K +2.27% | 157,402 0.11% of shares | low |
| Apr 7, 2026 | Malik Fady Ibraham Executive | Exercise | Common Stock | $27.3K | +4K +2.27% | 157,402 0.11% of shares | low |
| Jan 2, 2026 | Callos Andrew Executive | Exercise | Common Stock | $33.3K | +885 +1.75% | 51,325 0.04% of shares | low |
| Mar 2, 2026 | Callos Andrew Executive | Exercise | Common Stock | $33.3K | +886 +1.76% | 51,326 0.04% of shares | low |
| Feb 2, 2026 | Callos Andrew Executive | Exercise | Common Stock | $33.3K | +886 +1.76% | 51,326 0.04% of shares | low |
| Jun 24, 2026 | Lee Sung Executive | Exercise | Common Stock | $36.5K | +822 +0.82% | 100,838 0.07% of shares | low |
| Jun 29, 2026 | Lee Sung Executive | Exercise | Common Stock | $36.5K | +822 +1.30% | 64,231 0.05% of shares | low |
| Jun 29, 2026 | Lee Sung Executive | Exercise | Common Stock | $36.5K | +823 +1.26% | 66,355 0.05% of shares | low |
| May 5, 2026 | Wierenga Wendell Director | Exercise | Common Stock | $50.0K | +4K +12.35% | 36,669 0.03% of shares | low |
| Jun 24, 2026 | Lee Sung Executive | Exercise | Common Stock | $54.0K | +1K +1.10% | 101,951 0.07% of shares | low |
| Jun 24, 2026 | Lee Sung Executive | Exercise | Common Stock | $54.0K | +1K +1.13% | 99,828 0.07% of shares | low |
| Jun 29, 2026 | Lee Sung Executive | Exercise | Common Stock | $54.0K | +1K +1.73% | 65,344 0.05% of shares | low |
| Mar 2, 2026 | Callos Andrew Executive | Sell | Common Stock | $54.6K | -886 -1.73% | 50,440 0.04% of shares | low |
| Feb 2, 2026 | Callos Andrew Executive | Sell | Common Stock | $55.0K | -886 -1.73% | 50,440 0.04% of shares | low |
| Jan 2, 2026 | Callos Andrew Executive | Sell | Common Stock | $55.9K | -885 -1.72% | 50,440 0.04% of shares | low |